Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

2.48USD
3:06pm EDT
Change (% chg)

$-0.04 (-1.59%)
Prev Close
$2.52
Open
$2.53
Day's High
$2.57
Day's Low
$2.46
Volume
3,260
Avg. Vol
2,747
52-wk High
$4.21
52-wk Low
$2.24

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.59
Market Cap(Mil.): $28.81
Shares Outstanding(Mil.): 11.30
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 235.76 33.88
EPS (TTM): -0.82 -- --
ROI: -270.00 -5.45 13.21
ROE: -266.16 -6.94 15.18

BRIEF-Cleveland Biolabs Reports Quarterly Loss Per Share Of $0.11

* CLEVELAND BIOLABS INC - REVENUE FOR Q1 OF 2018 DECREASED TO $0.2 MILLION COMPARED TO $0.6 MILLION FOR Q1 OF 2017

May 15 2018

BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA

* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD

Mar 28 2018

BRIEF-Cleveland Biolabs Reports Qtrly Loss Per Share $0.10‍​

* CLEVELAND BIOLABS-ESTIMATES CASH,CASH EQUIVALENTS,SHORT-TERM INVESTMENTS AS OF DEC 31 ENOUGH TO FUND OPERATIONS FOR AT LEAST 1 YEAR AFTER 10-K FILING DATE Source text: (http://bit.ly/2FXHEdA) Further company coverage:

Mar 06 2018

Earnings vs. Estimates